Gregory Fraser
Stock Analyst at Truist Securities
(2.73)
# 2,135
Out of 5,058 analysts
39
Total ratings
57.14%
Success rate
17.13%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $78.52 | +14.62% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $175.74 | +16.65% | 2 | Aug 28, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $6.00 | +16.67% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $1.23 | +12,908.13% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.40 | +275.00% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $11.52 | -39.21% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $75.05 | -61.36% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $11.46 | +728.97% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $6.62 | +171.90% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $27.33 | +46.36% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $78.52
Upside: +14.62%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $175.74
Upside: +16.65%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $6.00
Upside: +16.67%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $1.23
Upside: +12,908.13%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.40
Upside: +275.00%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $11.52
Upside: -39.21%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $75.05
Upside: -61.36%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $11.46
Upside: +728.97%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $6.62
Upside: +171.90%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $27.33
Upside: +46.36%